Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Fuxing, Zhao"'
Autor:
Hengheng Zhang, Guoshuang Shen, Ping Yang, Meijie Wu, Jinming Li, Zitao Li, Fuxing Zhao, Hongxia Liang, Mengting Da, Ronghua Wang, Chengrong Zhang, Jiuda Zhao, Yi Zhao
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Background The incidence of autoimmune diseases and breast cancer is significantly higher in women compared to men. Previous observational studies have not conclusively determined the relationship between these two conditions. This study uti
Externí odkaz:
https://doaj.org/article/3b9e270aa8f34e3198eaf4fd7422d6e3
Autor:
Ping Yang, Hengheng Zhang, Jinming Li, Zitao Li, Zhen Liu, Miaozhou Wang, Fuxing Zhao, Jiuda Zhao, GuoShuang Shen, Yi Zhao
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 15 (2024)
Background: Antibody–drug conjugates (ADCs), as a new type of targeted drug, have been widely used in breast cancer patients in recent years. However, while achieving better efficacy, its hepatotoxicity should not be ignored. Objectives: To clarify
Externí odkaz:
https://doaj.org/article/a8598c337ae74462bff124a808056182
Publikováno v:
In Applied Thermal Engineering 1 December 2024 257 Part B
Autor:
Zhilin Liu, Jinming Li, Fuxing Zhao, Dengfeng Ren, Zitao Li, Yongzhi Chen, Shifen Huang, Zhen Liu, Yi Zhao, Miaozhou Wang, Huihui Li, ZhengBo Xu, Guoshuang Shen, Jiuda Zhao
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Triple-negative breast cancer (TNBC) is a life-threatening subtype of breast cancer with limited treatment options. Therefore, this network meta-analysis (NMA) aimed to evaluate and compare the effect of various neoadjuvant chemot
Externí odkaz:
https://doaj.org/article/6e906f96b27a4da7816719ae8f1bdf3b
Autor:
Mingqiang Shi, Zhoujuan Li, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Miaozhou Wang, Zhen Liu, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 2, Iss 2, Pp 81-90 (2024)
Background: Metastatic triple-negative breast cancer (mTNBC) is an aggressive histological subtype with poor prognosis. Several first-line treatments are currently available for mTNBC. This study conducted a network meta-analysis to compare these fir
Externí odkaz:
https://doaj.org/article/6439a61dbb12443393dd4799432f75d1
Autor:
Jinming Li, Guoshuang Shen, Zhen Liu, Yaobang Liu, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Qiqi Xie, Zitao Li, Zhilin Liu, Yi Zhao, Fei Ma, Xinlan Liu, Zhengbo Xu, Jiuda Zhao
Publikováno v:
Cancer Innovation, Vol 2, Iss 5, Pp 346-375 (2023)
Abstract Background The wide use of antibody‐drug conjugates (ADCs) is transforming the cancer‐treatment landscape. Understanding the treatment‐related adverse events (AEs) of ADCs is crucial for their clinical application. We conducted a meta
Externí odkaz:
https://doaj.org/article/75fdfea5bfbf420fa818fa7fc294863f
Autor:
Zhoujuan Li, Guoshuang Shen, Mingqiang Shi, Yonghui Zheng, Yumei Guan, Yuanfang Xin, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 3, Pp 205-215 (2023)
Background: A high body mass index (BMI) can indicate overweight or obesity and is a crucial risk factor for breast cancer survivors. However, the association between high BMI and prognosis in early-stage breast cancer (EBC) remains unclear. We aimed
Externí odkaz:
https://doaj.org/article/f2ed5ea842fe49c7a69ad1cde2cff7cd
Autor:
Yuyao Tang, Guoshuang Shen, Yuanfang Xin, Zhoujuan Li, Yonghui Zheng, Miaozhou Wang, Zhen Liu, Yi Zhao, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: The use of antibody–drug conjugates for the treatment of advanced-stage human epidermal growth factor receptor 2 (HER2)-low expression in breast cancer (BC) has shown prominent curative effects, which has led to increased academic inter
Externí odkaz:
https://doaj.org/article/91cecf92896d4f99a3319a770213ad2a
Autor:
Xingfa Huo, Guoshuang Shen, Tianzhuo Wang, Jinming Li, Qiqi Xie, Zhen Liu, Miaozhou Wang, Fuxing Zhao, Dengfeng Ren, Jiuda Zhao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMany systemic treatment options are available for patients with human epidermal growth factor 2 (HER2)-positive breast cancer brain metastases. However, it is unclear which pharmacological treatment option is the most beneficial.MethodsWe
Externí odkaz:
https://doaj.org/article/d3cdbd4c51a44552adbf87fb5fad421b
Autor:
Yuanfang Xin, Guoshuang Shen, Yonghui Zheng, Yumei Guan, Xingfa Huo, Jinming Li, Dengfeng Ren, Fuxing Zhao, Zhen Liu, Zitao Li, Jiuda Zhao
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Purpose Some studies have shown that Immune checkpoint inhibitors (ICIs) have a favorable efficacy in advanced triple negative breast cancer (TNBC) patients, but the results are controversial in neoadjuvant chemotherapy (NACT) stage. The pur
Externí odkaz:
https://doaj.org/article/7e5c3c4c18ff45ae9e8fc223d09d5bf1